Gilead Sciences (GILD) Buildings (2010 - 2025)

Gilead Sciences has reported Buildings for 16 years, with the latest figure at $4.6 billion in Q4 2025.

• For the quarter ending Q4 2025, Buildings rose 1.83% year-over-year to $4.6 billion; the trailing twelve-month figure through Dec 2025 stood at $4.6 billion (up 1.83% YoY), and the FY2025 full-year result was $4.6 billion, up 1.83% from the prior year.
• Buildings for Q4 2025 stood at $4.6 billion, up from $4.5 billion in the prior quarter.
• The five-year high for Buildings was $4.6 billion in Q4 2025, with the low at $3.8 billion in Q4 2021.
• Historically, Buildings has averaged $4.3 billion across 5 years, with a median of $4.4 billion in 2022.
• Annual changes were most pronounced in 2022 — Buildings increased 15.71% — and 2023, when it decreased 1.41%.
• Gilead Sciences' Buildings stood at $3.8 billion in 2021, then climbed by 15.71% to $4.4 billion in 2022, then dropped by 1.41% to $4.3 billion in 2023, then gained by 4.88% to $4.5 billion in 2024, then grew by 1.83% to $4.6 billion in 2025.
• The last three Buildings figures came in at $4.6 billion (Q4 2025), $4.5 billion (Q4 2024), and $4.3 billion (Q4 2023), per Business Quant data.